Product: Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
Reason for recall: Failed Stability Specifications
Recall initiated: 20221013
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated